Information for the public
Etelcalcetide (Parsabiv) is available on the NHS. It is a possible treatment for secondary hyperparathyroidism in adults on dialysis for chronic kidney disease, if a drug called cinacalcet is not suitable.
If you are not eligible for etelcalcetide but are already taking it, you should be able to continue until you and your doctor decide when best to stop.
Is this treatment right for me?
Your healthcare professionals should give you clear information, talk with you about your options and listen carefully to your views and concerns. Your family can be involved too, if you wish. Read more about making decisions about your care.
Questions to think about
- How well does it work compared with other treatments?
- What are the risks or side effects? How likely are they?
- How will the treatment affect my day-to-day life?
- What happens if the treatment does not work?
- What happens if I do not want to have treatment? Are there other treatments available?
Information and support
NHS Choices may be a good place to find out more.
These organisations can give you advice and support:
- Kidney Care UK, 0142 054 1424
- Kidney Research UK, 0300 303 1100
- National Kidney Federation, 0800 169 0936
- British Thyroid Foundation, 0142 381 0093
- Hypopara UK, 01342 316315
NICE is not responsible for the quality or accuracy of any information or advice provided by these organisations.
ISBN: 978-1-4731-2576-6
This page was last updated: